Implantable Cardioverter Defibrillator Market Growth – at a CAGR of 2.7% During Forecast Period 2020-2028

Growing inclination towards a sedentary lifestyle and rising prevalence of cardiovascular diseases worldwide are some key factors contributing to revenue growth of the global market.

Growing inclination towards a sedentary lifestyle and rising prevalence of cardiovascular diseases worldwide are some key factors contributing to revenue growth of the global market

According to Emergen Research, the global implantable cardioverter defibrillator market size was USD 7.11 billion in 2020 and is expected to reach USD 8.81 billion in 2028 and register a revenue CAGR of 2.7% during the forecast period, 2021-2028.

Market Dynamics:

The global implantable cardioverter defibrillator market revenue growth is primarily attributed to factors such as growing inclination towards a sedentary lifestyle, rising burden of chronic diseases such as obesity, diabetes, and high blood pressure, increasing prevalence of cardiovascular diseases across the globe, rise in geriatric population, and increasing risks of heart disease in younger people due to smoking, alcohol consumption, and stress and anxiety. Implantable cardioverter-defibrillator is a battery-powered device that is placed inside the chest to detect and stop cardiac arrhythmia (irregular heartbeat). The device continuously monitors the heartbeat and administers electric shocks when required to restore the normal cardiac rhythm.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/732

Growing availability of public-access defibrillators, rising demand for training programs on implantable cardioverter defibrillators (ICDs) in healthcare facilities, technological advances in defibrillators, and growing demand for implantable cardioverter defibrillators are among the other key factors expected to support the global market revenue growth over the forecast period. Introduction of MRI-compatible implantable cardioverter-defibrillators, rapid adoption of subcutaneous ICDs due to advantages over transvenous ICDs, and increasing government and private investments in research & development of advanced cardiac devices are other important factors driving revenue growth of this market. However, market revenue growth can be hampered to some extent due to certain unfavorable factors. Potential risks associated with implantable cardioverter defibrillators, such as swelling, bleeding, bruising, and damaged blood vessels caused by infection at the implant site, and lack of skilled healthcare professionals are key factors that can potentially restrain market revenue growth to a certain extent going ahead.

COVID-19 Impact Analysis:

  • Social distancing and restrictions severely disrupted businesses and operations
  • Lockdowns caused disruptions in transportation and logistics
  • Impacted manufacturing activities and mining operations globally
  • Took a toll on economy of various countries
  • Caused sudden and drastic downturn in economic activity
  • Disrupted agriculture, fisheries, dairy, and other sectors
  • Caused loss of employment and financial crisis
  • Supply impacts were further compounded owing to reduced disposable income
  • Emergence of variants continue to cause concerns and impact normal routines

Subcutaneous ICD Segment Accounted for Largest Revenue Share in 2020:

The subcutaneous ICD segment dominated other segments in terms of revenue share in the global market in 2020. Growing demand for subcutaneous implantable cardioverter defibrillators due to several advantages over transvenous ICDs and increasing use in treatment of congenital heart diseases are among the main factors driving revenue growth of this segment. Key benefits of Subcutaneous ICDs are absence of leads within the heart and preservation of central venous circulation.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/implantable-cardioverter-defibrillator-market

Hospitals & Clinics Segment to Account for Fastest Revenue CAGR:

The hospitals & clinics segment is expected to register the fastest revenue growth rate in the global market over the forecast period. Rising prevalence of cardiovascular diseases, increasing patient pool, continuous advancements in healthcare infrastructure, and growing use of advanced cardiac devices such as implantable cardioverter defibrillators in hospitals and clinics are major factors supporting revenue growth of this segment.

North America Accounted for Largest Revenue Share in 2020:

Among regional markets, the North America implantable cardioverter defibrillator market accounted for the largest revenue share in the global market in 2020. Increasing burden of diabetes, obesity, and high blood pressure, rising prevalence of cardiovascular diseases, and increasing risks of heart disease in children and young adults are some key factors boosting demand for cardioverter defibrillators and are expected to drive market revenue growth over the forecast period. In addition, rapid adoption of advanced cardiac devices in healthcare facilities and presence of state-of-the-art healthcare infrastructure in the region are some other key factors expected to contribute to market revenue growth in the region.

Major Companies in the Global Implantable Cardioverter Defibrillator Market Include:

  • Boston Scientific Corporation
  • Abbott Laboratories
  • Biotronik
  • Medtronic PLC
  • LivaNova PLC
  • Imricor Medical Systems
  • MicroPort Scientific Corporation
  • Nohen Kohden Corporation
  • Sorin Group
  • Koninklijke Philips N.V.
  • Fukuda Denshi Co. Ltd.
  • Physio-Control, Inc.

We are Offering Limited Time Discount (Grab your Copy Now) @ https://www.emergenresearch.com/request-discount/732

For the purpose of this report, Emergen Research has segmented the global implantable cardioverter defibrillator market based on product type, end-use, and region:

Product Type Outlook (Revenue, USD Billion; 2018–2028)

  • Transvenous ICD
  • Single Chamber ICD
  • Dual Chamber ICD
  • CRT-D (cardiac resynchronization therapy-defibrillator)
  • Subcutaneous ICD

End-use Outlook (Revenue, USD Billion; 2018–2028)

  • Hospitals & Clinics
  • Ambulatory Surgery Centers
  • Others

Region Outlook (Revenue, USD Billion; 2018-2028)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Turkey
    • Rest of Middle East & Africa

Let us Know Your Custom Requirements for this Report [Customization Available]@ https://www.emergenresearch.com/request-for-customization/732

Other Reports From Emergen Research Ever-growing Database:

Mechanical Keyboard Market By Product Type (Clicky Switches, Linear Switches, Tactile/Non-Clicky Switches), By Technology (Wireless, Wired), By Application (Gaming, Typing, Others), By End-Use (Commercial, Residential, Professional Gamers), and By Region Forecast to 2028.

Sound Bar Market Size, Share, Trends, By Product Type (Active Sound Bar, Passive Sound Bar), By Connectivity (Wired, Wireless), By Installation Type (Table-top, Wall-mounted), By Application, and By Region Forecast to 2028.

Brain Computer Interface Market, By Component Type (Hardware, Software), By Product Type, By Application (Healthcare, Smart Home Control, Communication & Control, Entertainment & Gaming), By End-Use, and By Region Forecast to 2030.

E Skin Market Size, Share, Trends, By Product (Electronic skinsuit and Electronic patches), By Component (Stretchable circuits, Photovoltaics system, and Others), By Sensor Type, By Application, and By Region Forecast to 2030.

Drone Inspection and Monitoring Market By Solution (Software, Services, Platform, Infrastructure), By Technology (Remotely Piloted, Optionally Piloted, Fully Autonomous), By Type, By Application, By End-Use, and By Region Forecast to 2030.

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Press Release Available @ https://www.emergenresearch.com/press-release/global-implantable-cardioverter-defibrillator-market